Nuvalent

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Nuvalent and other ETFs, options, and stocks.

About NUVL

Nuvalent, Inc. operates as a preclinical stage biopharmaceutical company. The company creates precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. 

CEO
James R. Porter
CEOJames R. Porter
Employees
40
Employees40
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2017
Founded2017
Employees
40
Employees40

NUVL Key Statistics

Market cap
1.78B
Market cap1.78B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
201.68K
Average volume201.68K
High today
$31.92
High today$31.92
Low today
$30.38
Low today$30.38
Open price
$31.25
Open price$31.25
Volume
60.58K
Volume60.58K
52 Week high
$40.43
52 Week high$40.43
52 Week low
$7.09
52 Week low$7.09

NUVL Earnings

-$3.17
-$2.11
-$1.06
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Mar 28, Pre-Market
ActualExpected Mar 28, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.